---
document_datetime: 2025-07-15 11:57:05
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/trabectedin-accord-epar-all-authorised-presentations_en.pdf
document_name: trabectedin-accord-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7923726
conversion_datetime: 2025-12-27 13:40:23.973817
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name    | Strength   | Pharmaceutical Form                              | Route of Administration   | Immediate Packaging   | Pack size   |
|------------------|--------------------|------------|--------------------------------------------------|---------------------------|-----------------------|-------------|
| EU/1/24/1902/001 | Trabectedin Accord | 0.25 mg    | Powder for concentrate for solution for infusion | Intravenous use           | vial (glass)          | 1 vial      |
| EU/1/24/1902/002 | Trabectedin Accord | 1 mg       | Powder for concentrate for solution for infusion | Intravenous use           | vial (glass)          | 1 vial      |